Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
52W High
$116.25
52W Low
$72.58
MA Status:
50D: Above
200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.38
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
13.04
Forward P/E (<15 better)
8.64
EV/EBITDA (<8 favorable)
9.51
EV/Revenue (<3 favorable)
3.74
P/S (TTM) (<3 favorable)
3.32
P/B (<3 favorable)
4.31
Ownership
Institution‑heavySource: Overview
Insiders (1–5% typical)
0.07%
Institutions (25–75% balanced)
80.59%
Shares Outstanding
2,497,780,000
Float
2,493,837,000
Dividend Yield (2–6% sweet spot)
0.04%
Ex‑Dividend Date
2025-09-15
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
63,616,000,000
Gross Profit (TTM)
49,245,999,000
EPS (TTM)
6.49
Profit Margin (>10% good)
0.26%
Operating Margin (TTM) (higher better)
0.38%
ROE (TTM) (>15% strong)
0.35%
EPS YoY (Quarterly) (>10% good)
-0.18
Revenue YoY (Quarterly) (>8% good)
-0.02
Momentum
Bearish momentumValue
0.6153
Previous
0.7073
Trend
Falling
Signal Cross
No cross
As of
Sep. 10, 2025